Loading…
Legislative Progress
Momentum (last 30 days)
10
score
0 actions · 5 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 10,940 other HR bills in the 119th — cohort avg 30d
Headache Education, Access, Diagnosis, and Care Health Equity Act or the HEADACHE Act This bill temporarily establishes a federal initiative, an advisory council, and related reporting to address headache disorders. The bill defines headache disorder as a medical condition for which a headache is a principal symptom, including primary conditions (e.g., tension-type headaches, migraines) and secondary conditions (i.e., headaches that are symptoms of other health conditions). Specifically, the Department of Health and Human Services (HHS) must establish a coordinated federal initiative to take actions that advance research and improve care for headache disorders. Also, HHS must establish an advisory council comprised of certain federal and non-federal members to advise HHS on headache disorders and hold annual research meetings. Finally, HHS must annually report to Congress on headache disorders, including (1) an annually updated national plan, (2) evaluations of all relevant federally funded efforts, and (3) recommendations for priority actions. The requirements of the bill sunset five years after the bill’s enactment.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2026 · third_quarter · Health Issues
Abortion access (general); Access to mifepristone (general); Contraception (general); Maternal mortality and morbidity (general); H.R. 8651/S. _____, Advancing Safe Medications for Moms and Babies Act; Obstetric and gynecologic care in rural and underserved areas (general); impact of closures of labor and delivery units in rural hospitals on patient access to care and maternal morbidity and mortality; abortion training in obstetrics and gynecology residency programs (general); Teaching Health Center Graduate Medication Education program (general); implementation of P.L. 119-21, One Big, Beautiful Bill Act; implementation of Sec. 6501 of P.L. 119-75, Preventing Maternal Deaths Reauthorization Act; Telemedicine (general); S. 380/H.R. 1254, Rural Obstetrics Readiness Act; S. 1834/H.R. 3762, Supporting Healthy Moms and Babies Act; H.R. 7973, Momnibus Act H.R. 9441, SAFE Training for OBGYNs Act; H.R. 9090/S. 4503, Advancing Menopause Care and Mid-Life Womens Health Act; H.R. 10600, Abortion is Health Care Everywhere Act; S. ____, Know Your Risk Act; S. 3254/H.R. 6238, NIH IMPROVE Act; H.R. 9946, Equity in STI Testing Act; H.R. 3387, No Surprise Bills for New Moms Act; H.R. 9842, State Offices of Womens Health Support and Expansion Act; H.R. 2028/S. 942, REDI Act; H.R. 5536, HEADACHE Act; H.Res.739/S.Res.401, National Stillbirth Prevention & Awareness Day Resolution; S. ____, Jeanette Acosta Invest in Womens Health Act; HR.____ /S. 5554, Ovarian Cancer Improving and Modernizing Prevention, Access, Care, and Testing (IMPACT) Act; H.R. ____, Improving Access to WIC Act; H.R. ____/S. ____, Support Through Loss Act; H.R. 6468/S. 5232, Rural Residency Planning and Development Act; H.R. _____/S. 4445, Right to IVF Act; S. 4494, maternal mortality review committees (general); Patient-physician relationship (general); Obstetrician-gynecologist workforce (general); Substance use disorder during pregnancy (general); Maternal mental health (general); Insurance coverage for infertility (general); Protections for in vitro fertilization (general); Vaccination (general); childhood vaccine recommendations (general); Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC) recommendations (general); inclusion of pregnant and lactating women in clinical trials (general); NIH/NICHD womens health research (general); clinical research workforce development (general); access to fertility services and treatments (general); Advisory Committee on Immunization Practices (ACIP); COVID vaccine during pregnancy (general); United States Preventive Services Taskforce (general); hormone therapy for menopause symptoms (general); Pregnancy Risk Assessment Monitoring System (PRAMS); Maternal Mortality Review Information Application (MMRIA); OMB Regulation for Federal Financial Assistance (OMB-2026-0034-0001); estradiol patch shortage (general); menopause education (general); risk-reducing salpingectomy (general).
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $250,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Taxation/Internal Revenue Code
HR 5536-Doug LaMalfa Federal Disaster Tax Relief HR 2089-Generating Retirement Ownership Through Long-Term Holding
Client expense: $770,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
2026 · third_quarter · Health Issues
Issues pertaining to the 340B Drug Discount Program - H.R. 5256, the 340B ACCESS Act; H.R.4581 & S. 2372, 340B PATIENTS Act of 2025; H.R. 9504, Tax Exempt Hospital Transparency Act; S.5244, SUSTAIN 340B Act; H.R.9599, SECURE 340B Act Step therapy reform - H.R. 5509 & S. 2903, Safe Step Act Neuroscience Drug Program - FY 2026 and FY2027 AgFDA Appropriations BRAIN Initiative - FY 2026 and FY2027 Labor-HHS Appropriations Issues related to DTC advertising regulations Headache disorders treatment and research - H.R. 5536, HEADACHE Act of 2025 Research and services for epilepsy - H.R. 1189 & S. 494, National Plan for Epilepsy Act Issues pertaining to prior authorization - HR 9396, Prior Authorization Accountability Act Issues pertaining to transparency - HR 9393, Lower Costs, More Transparency Act Issues pertaining to Pediatric Priority Review Voucher program at the FDA - H.R.10359, Priority for Pediatric Cures Act
Client expense: $130,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Taxation/Internal Revenue Code
HR 5536-Doug LaMalfa Federal Disaster Tax Relief HR 2089-Generating Retirement Ownership Through Long-Term Holding
Client expense: $640,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
2026 · second_quarter · Health Issues
Issues pertaining to the 340B Drug Discount Program - H.R. 5256, the 340B ACCESS Act; H.R.4581 & S. 2372, 340B PATIENTS Act of 2025; H.R. 9504, Tax Exempt Hospital Transparency Act Step therapy reform - H.R. 5509 & S. 2903, Safe Step Act Neuroscience Drug Program - FY 2026 and FY2027 AgFDA Appropriations BRAIN Initiative - FY 2026 and FY2027 Labor-HHS Appropriations Issues related to DTC advertising regulations Headache disorders treatment and research - H.R. 5536, HEADACHE Act of 2025 Research and services for epilepsy - H.R. 1189 & S. 494, National Plan for Epilepsy Act Issues pertaining to prior authorization - HR 9396, Prior Authorization Accountability Act Issues pertaining to transparency - HR 9393, Lower Costs, More Transparency Act
Client expense: $180,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Taxation/Internal Revenue Code
HR 5536-Doug LaMalfa Federal Disaster Tax Relief HR 2089-Generating Retirement Ownership Through Long-Term Holding
Client expense: $670,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
2026 · first_quarter · Health Issues
Issues pertaining to the 340B Drug Discount Program - H.R. 5256, the 340B ACCESS Act; H.R.4581 & S. 2372, 340B PATIENTS Act of 2025 Issues pertaining to Pharmacy Benefit Managers - H.R.4317, PBM Reform Act of 2025; H.R.6703, Lower Health Care Premiums for All Americans Act Step therapy reform - H.R. 5509 & S. 2903, Safe Step Act Neuroscience Drug Program - FY 2026 and FY2027 AgFDA Appropriations BRAIN Initiative - FY 2026 and FY2027 Labor-HHS Appropriations Reauthorization of the Pediatric Priority Review Voucher program at the FDA Issues related to DTC advertising regulations Pediatric rare diseases - H.R. 1262 & S. 932, Give Kids a Chance Act of 2025 Headache disorders treatment and research - H.R. 5536, HEADACHE Act of 2025 Research and services for epilepsy - H.R. 1189 & S. 494, National Plan for Epilepsy Act
Client expense: $130,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Health Issues
Issues pertaining to the 340B Drug Discount Program - H.R. 5256, the 340B ACCESS Act; H.R.4581 & S. 2372, 340B PATIENTS Act of 2025 Issues pertaining to Pharmacy Benefit Managers - H.R.4317, PBM Reform Act of 2025; H.R.6703, Lower Health Care Premiums for All Americans Act Step therapy reform - H.R. 5509 & S. 2903, Safe Step Act Neuroscience Drug Program - FY 2026 AgFDA Appropriations BRAIN Initiative - FY 2026 Labor-HHS Appropriations Migraine care - FY 2026 MilCon Appropriations Reauthorization of the Pediatric Priority Review Voucher program at the FDA Issues related to DTC advertising regulations Pediatric rare diseases - H.R. 1262 & S. 932, Give Kids a Chance Act of 2025 Headache disorders treatment and research - H.R. 5536, HEADACHE Act of 2025 Research and services for epilepsy - H.R. 1189 & S. 494, National Plan for Epilepsy Act
Client expense: $170,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Health Issues
Abortion access (general); Access to mifepristone (general); Contraception (general); Maternal mortality and morbidity (general); H.R. _____/S. _____, Advancing Safe Medications for Moms and Babies Act;;Obstetric and gynecologic care in rural and underserved areas (general); impact of closures of labor and delivery units in rural hospitals on patient access to care and maternal morbidity and mortality; abortion training in obstetrics and gynecology residency programs (general); Teaching Health Center Graduate Medication Education program (general); P.L. 119-21, One Big, Beautiful Bill Act; H.R. 1909/S. 2621, Preventing Maternal Deaths Reauthorization Act of 2025; Telemedicine (general); S. 380/H.R. 1254, Rural Obstetrics Readiness Act; S. 1834/H.R. 3762, Supporting Healthy Moms and Babies Act; H.R. 6242/S. 3274, Healthy MOM Act; H.R. 6096, NEST Act; H.R. 3670, IHS Provider Expansion Act; S. 1380/H.R. 4681, Specialty Physicians Advancing Rural Care (SPARC) Act; H.R. _____/S. _____, Black Maternal Health Momnibus Act; H.R. 5536, HEADACHE Act; H.R. 3633, Prevent HPV Cancers Act; maternal mortality review committees (general); Patient-physician relationship (general); Obstetrician-gynecologist workforce (general); Substance use disorder during pregnancy (general); Maternal mental health (general); Insurance coverage for infertility (general); Protections for in vitro fertilization (general); Vaccination (general); Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC) recommendations (general); NIH/NICHD womens health research (general); access to fertility services and treatments (general); Restorative Reproductive Medicine (general); funding for providers of reproductive health care (general); prepregnancy health (general); Affordable Care Act (general); Advisory Committee on Immunization Practices (ACIP); COVID vaccine during pregnancy (general); S.____, Maternal Health Pandemic Response Act; United States Preventive Services Taskforce (general); hormone therapy for menopause symptoms (general acetaminophen use during pregnancy (general); SSRI use during pregnancy (general); Pregnancy Risk Assessment Monitoring System (PRAMS);; biomarker testing for preeclampsia (general); reproductive coercion (general);Richardson Waiver (general);
2025 · third_quarter · Health Issues
Issues pertaining to Pharmacy Benefit Managers Step therapy reform -the Safe Step Act Neuroscience Drug Program - FY 2026 AgFDA Approps BRAIN Initiative - FY 2026 Labor-HHS Appropriations Migraine care - FY 2026 MilCon Approps Reauthorization of the Pediatric Priority Review Voucher program at the FDA Issues related to DTC advertising regulations Give Kids a Chance Act of 2025 H.R. 1262, S. 932 The HEADACHE Act of 2025 - H.R. 5536 National Plan for Epilepsy Act -- H.R. 1189, S. 494
Client expense: $140,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Health Issues
Issues pertaining to Pharmacy Benefit Managers Step therapy reform -the Safe Step Act Neuroscience Drug Program - FY 2026 AgFDA Approps BRAIN Initiative - FY 2026 Labor-HHS Appropriations Migraine care - FY 2026 MilCon Approps Reauthorization of the Pediatric Priority Review Voucher program at the FDA Issues related to DTC advertising regulations Give Kids a Chance Act of 2025 H.R. 1262, S. 932 The HEADACHE Act of 2025 - H.R. 5536 National Plan for Epilepsy Act -- H.R. 1189, S. 494
Client expense: $140,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Democratic |
| MA |
| Becca Balint | Democratic | VT |
| Brian K. Fitzpatrick | Republican | PA |
| Brittany Pettersen | Democratic | CO |
| Chellie Pingree | Democratic | ME |
| Chrissy Houlahan | Democratic | PA |
| Daniel S. Goldman | Democratic | NY |
| Deborah K. Ross | Democratic | NC |
| Dina Titus | Democratic | NV |
| Donald Norcross | Democratic | NJ |
| Eleanor Holmes Norton | Democratic | DC |
| Emanuel Cleaver | Democratic | MO |
| Emily Randall | Democratic | WA |
| Eugene Simon Vindman | Democratic | VA |
| Frank J. Mrvan | Democratic | IN |
| Frederica S. Wilson | Democratic | FL |
| Gabe Vasquez | Democratic | NM |
| Haley M. Stevens | Democratic | MI |
| Jahana Hayes | Democratic | CT |
| James P. McGovern | Democratic | MA |
| James R. Walkinshaw | Democratic | VA |
| Jamie Raskin | Democratic | MD |
| Janelle S. Bynum | Democratic | OR |
| Jerrold Nadler | Democratic | NY |
| Jesús G. "Chuy" García | Democratic | IL |
| Jonathan L. Jackson | Democratic | IL |
| Josh Gottheimer | Democratic | NJ |
| Josh Riley | Democratic | NY |
| Julia Brownley | Democratic | CA |
| Julie Johnson | Democratic | TX |
| Laura Friedman | Democratic | CA |
| Maggie Goodlander | Democratic | NH |
| Michael Lawler | Republican | NY |
| Mike Kelly | Republican | PA |
| Nick LaLota | Republican | NY |
| Nicole Malliotakis | Republican | NY |
| Nikki Budzinski | Democratic | IL |
| Patrick Ryan | Democratic | NY |
| Paul Tonko | Democratic | NY |
| Rashida Tlaib | Democratic | MI |
| Ro Khanna | Democratic | CA |
| Robin L. Kelly | Democratic | IL |
| Ryan Mackenzie | Republican | PA |
| Salud O. Carbajal | Democratic | CA |
| Sam Graves | Republican | MO |
| Sarah McBride | Democratic | DE |
| Seth Moulton | Democratic | MA |
| Sharice Davids | Democratic | KS |
| Shri Thanedar | Democratic | MI |
| Stephen F. Lynch | Democratic | MA |
| Steve Cohen | Democratic | TN |
| Terri A. Sewell | Democratic | AL |
| Thomas H. Kean, Jr. | Republican | NJ |
| Thomas R. Suozzi | Democratic | NY |
| Valerie P. Foushee | Democratic | NC |
| Yvette D. Clarke | Democratic | NY |
| Zoe Lofgren | Democratic | CA |
Client expense: $230,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE